New anti-seizure medication for elderly epilepsy patients - a critical narrative review.

Alexandra Rohracher; Gudrun Kalss; Giorgi Kuchukhidze; C Neuray; Markus Leitinger; Julia Höfler; Rudolf Kreidenhuber; Fabio Rossini; K Volna; Matthias Mauritz; N Poppert; S Lattanzi; F Brigo; Eugen Trinka

doi:10.1080/14656566.2020.1843636

New anti-seizure medication for elderly epilepsy patients - a critical narrative review.

Alexandra Rohracher (Erstautor/-in), Gudrun Kalss (Co-Autor/-in), Giorgi Kuchukhidze (Co-Autor/-in), C Neuray, Markus Leitinger (Co-Autor/-in), Julia Höfler (Co-Autor/-in), Rudolf Kreidenhuber (Co-Autor/-in), Fabio Rossini (Co-Autor/-in), K Volna, Matthias Mauritz (Co-Autor/-in), N Poppert, S Lattanzi, F Brigo, Eugen Trinka^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinik für Neurologie

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

26 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	621-634
Fachzeitschrift	EXPERT OPINON ON PHARMACOTHERAPY
Jahrgang	22
Ausgabenummer	5
DOIs	https://doi.org/10.1080/14656566.2020.1843636
Publikationsstatus	Veröffentlicht - 2021

Zugriff auf Dokument

10.1080/14656566.2020.1843636

Dieses zitieren

Rohracher, A., Kalss, G., Kuchukhidze, G., Neuray, C., Leitinger, M., Höfler, J., Kreidenhuber, R., Rossini, F., Volna, K., Mauritz, M., Poppert, N., Lattanzi, S., Brigo, F., & Trinka, E. (2021). New anti-seizure medication for elderly epilepsy patients - a critical narrative review. EXPERT OPINON ON PHARMACOTHERAPY, 22(5), 621-634. https://doi.org/10.1080/14656566.2020.1843636

@article{c2be387f02f046b09ef719f3c703ab45,

title = "New anti-seizure medication for elderly epilepsy patients - a critical narrative review.",

keywords = "PARTIAL-ONSET SEIZURES, NEWLY-DIAGNOSED EPILEPSY, ADJUNCTIVE ESLICARBAZEPINE ACETATE, CONTROLLED-RELEASE CARBAMAZEPINE, LACOSAMIDE CARDIAC SAFETY, INTIMA-MEDIA THICKNESS, DOUBLE-BLIND, STATUS EPILEPTICUS, ANTIEPILEPTIC DRUG, PHASE-III",

author = "Alexandra Rohracher and Gudrun Kalss and Giorgi Kuchukhidze and C Neuray and Markus Leitinger and Julia H{\"o}fler and Rudolf Kreidenhuber and Fabio Rossini and K Volna and Matthias Mauritz and N Poppert and S Lattanzi and F Brigo and Eugen Trinka",

note = "all but Lattanzi & Brigo: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, affiliated partner of the ERN EpiCARE Center for Cognitive Neuroscience, Paracelsus Medical University Salzburg, and Christian Doppler Medical Centre , Salzburg, Austria.",

year = "2021",

doi = "10.1080/14656566.2020.1843636",

language = "English",

volume = "22",

pages = "621--634",

journal = "EXPERT OPINON ON PHARMACOTHERAPY",

issn = "1465-6566",

number = "5",

}

Rohracher, A, Kalss, G , Kuchukhidze, G, Neuray, C, Leitinger, M , Höfler, J , Kreidenhuber, R , Rossini, F, Volna, K, Mauritz, M, Poppert, N, Lattanzi, S, Brigo, F & Trinka, E 2021, 'New anti-seizure medication for elderly epilepsy patients - a critical narrative review.', EXPERT OPINON ON PHARMACOTHERAPY, Jg. 22, Nr. 5, S. 621-634. https://doi.org/10.1080/14656566.2020.1843636

TY - JOUR

T1 - New anti-seizure medication for elderly epilepsy patients - a critical narrative review.

AU - Rohracher, Alexandra

AU - Kalss, Gudrun

AU - Kuchukhidze, Giorgi

AU - Neuray, C

AU - Leitinger, Markus

AU - Höfler, Julia

AU - Kreidenhuber, Rudolf

AU - Rossini, Fabio

AU - Volna, K

AU - Mauritz, Matthias

AU - Poppert, N

AU - Lattanzi, S

AU - Brigo, F

AU - Trinka, Eugen

N1 - all but Lattanzi & Brigo: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, affiliated partner of the ERN EpiCARE Center for Cognitive Neuroscience, Paracelsus Medical University Salzburg, and Christian Doppler Medical Centre , Salzburg, Austria.

PY - 2021

Y1 - 2021

KW - PARTIAL-ONSET SEIZURES

KW - NEWLY-DIAGNOSED EPILEPSY

KW - ADJUNCTIVE ESLICARBAZEPINE ACETATE

KW - CONTROLLED-RELEASE CARBAMAZEPINE

KW - LACOSAMIDE CARDIAC SAFETY

KW - INTIMA-MEDIA THICKNESS

KW - DOUBLE-BLIND

KW - STATUS EPILEPTICUS

KW - ANTIEPILEPTIC DRUG

KW - PHASE-III

U2 - 10.1080/14656566.2020.1843636

DO - 10.1080/14656566.2020.1843636

M3 - Review article

C2 - 33111598

SN - 1465-6566

VL - 22

SP - 621

EP - 634

JO - EXPERT OPINON ON PHARMACOTHERAPY

JF - EXPERT OPINON ON PHARMACOTHERAPY

IS - 5

ER -